Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-005016
Filing Date
2015-11-13
Accepted
2015-11-13 10:12:31
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cbmg_10q.htm 10-Q 1582099
2 CERTIFICATION cbmg_ex311.htm EX-31.1 16624
3 CERTIFICATION cbmg_ex312.htm EX-31.2 16594
4 CERTIFICATION cbmg_ex321.htm EX-32.1 10492
  Complete submission text file 0001354488-15-005016.txt   4901968

Data Files

Seq Description Document Type Size
5 cmbg-20150930.xml EX-101.INS 697280
6 cmbg-20150930.xsd EX-101.SCH 50213
7 cmbg-20150930_cal.xml EX-101.CAL 61005
8 cmbg-20150930_def.xml EX-101.DEF 101194
9 cmbg-20150930_lab.xml EX-101.LAB 327613
10 cmbg-20150930_pre.xml EX-101.PRE 245685
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36498 | Film No.: 151227355
SIC: 2836 Biological Products, (No Diagnostic Substances)